Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 89 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $856,642 | -19.7% | 157,182 | 0.0% | 0.08% | -33.6% |
| Q2 2023 | $1,067,266 | +144.3% | 157,182 | +80.3% | 0.12% | +164.4% |
| Q1 2023 | $436,782 | +2.7% | 87,182 | 0.0% | 0.04% | -26.2% |
| Q4 2022 | $425,448 | -66.2% | 87,182 | 0.0% | 0.06% | -64.3% |
| Q3 2022 | $1,257,000 | -39.0% | 87,182 | -36.0% | 0.17% | -46.7% |
| Q2 2022 | $2,060,000 | -27.4% | 136,182 | -43.0% | 0.32% | -12.3% |
| Q1 2022 | $2,839,000 | -43.6% | 238,982 | -23.0% | 0.37% | -27.4% |
| Q4 2021 | $5,033,000 | -33.6% | 310,494 | +16.9% | 0.50% | -57.4% |
| Q3 2021 | $7,583,000 | +55.5% | 265,700 | +84.1% | 1.18% | +57.6% |
| Q2 2021 | $4,877,000 | – | 144,300 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
| Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
| MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
| Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
| First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
| Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
| Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
| Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |